Enfermedad Pulmonar Obstructiva Cronica: Mip Karla Cortés

ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA MIP KARLA CORTÉS

DEFINICION

• ENFERMEDAD FRECUENTE, PREVENIBLE Y TRATABLE • SINTOMAS RESPIRATORIOS • LIMTACION DEL FLUJO AEREO PERSISTENTE

ANOMALIAS DE VIAS RESPIRATORIAS O ALVEOLARES • vias aereas pequeñas • destruccion del parenquima

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

ETIOLOGIA

TABAQUISMO

CONTAMINACION ATMOSFERICA

EXPOSICION LABORAL

COMBUSTIBLES BIOMASA

GENETICA AAT

HIPERSENSIBILIDAD DE VA

MAL DESARROLLO PULMONAR

INFECCIONES

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

DIAGNOSTICO

DIFERENCIAL: • ASMA • INSUFICIENCIA CARDIACA CONGESTIVA • BRONQUIECTASIAS • TB • BRONQUIOLITIS OBLITERANTE

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

EVALUACION Y CLASIFICACION

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

ESPIROMETRIA

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

RX DE TORAX

TRATAMIENTO

• MEDIDAS EN TTO • DEJAR DE FUMAR • VACUNAS • ANTIGRIPAL • NEUMOCOCICA (REDUCE NEUMONIA)

• BRONCODIL NO DE ACCION CORTA (LABA (SALMETEROL Y FORMOTEROL 2XDIA))

• ANTIMUSC TIOTROPIO • METILXANTINAS • CORTICOESTEROIDES Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)

EPOC ESTABLE

National Institute for Clinical Excellence. Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care. Quick reference guide 2004.

OXIGENO • Pacientes con paO2 <55 mmHg respirando aire ambiente • paO2 entre 56 y 59 mmHg con signos de HTP • Insuficiencia cardiaca congestiva

• Arritmias • Edema periférico • Hematocrito mayor al 55%.

• La ATS/ERS3 y la NICE4 recomiendan su administración en pacientes • Desaturaciones nocturnas >30% del sueño